Ulthera (Merz) Ulthera System (Ultherapy)

HIFU/Ultrasound Lifting · Microfocused ultrasound + DeepSEE imaging

Legacy-used-marketFDA status under reviewBe the first to review

What it's actually cleared for: Original Ulthera System came through de novo DEN080006 (2009, eyebrow lift), with 510(k)s adding lift of lax submental and neck tissue (K121700, 2012) and decollete lines (K134032, 2014); PRIME cleared under K233996 (2024) with subsequent 2025-26 clearances expanding the platform — all confirmed via openFDA; match the K-number to the exact console model.

Last verified: August 6, 2026 · How we verify

New: $130k–$175k|Used: $20k–$60kmarket estimate, no email required

Save device

Bottom line

Ultherapy is still the brand-name king of non-surgical lifting, and a used legacy Ulthera system at $15k-45k looks like the bargain of the used market — until you understand the machine is worthless without Merz-supplied transducers, and Merz controls exactly who gets them. Transducers are serialized, chip-locked consumables sold only to accounts Merz recognizes — a gray-market system you can't register is a paperweight. If you can establish a legitimate Merz account (verify in writing before wiring money), legacy Ultherapy remains highly profitable; otherwise budget for PRIME at full freight. This is the single most important diligence item in the used-Ultherapy market.

Overview

Only FDA-cleared US lift claim for years; transducers consumable

How it works

The science

Microfocused ultrasound with visualization (MFU-V): the transducer images the tissue plane in real time (DeepSEE), then delivers focused thermal coagulation points at precise depths — 4.5mm (SMAS/platysma), 3.0mm (deep dermis), 1.5mm (superficial dermis) — triggering neocollagenesis and gradual lift over 2-6 months. The only energy device with FDA-cleared "lift" language for brow, submental, and neck, plus decollete wrinkle improvement. Results are line-count-dependent; skimped counts are the #1 cause of "Ultherapy didn't work" reviews.

Patented tech

DeepSEE is the real differentiator — transducer ultrasound imaging confirms coupling and target depth before firing, which no blind-delivery HIFU clone offers. "See what you treat" is load-bearing, not just branding.

Origin

Mesa, Arizona, USA (Ulthera, Inc., a Merz Aesthetics company).

FDA & regulatory status

FDA status under reviewRegulatory status not yet verified

What it's actually cleared for:

Original Ulthera System came through de novo DEN080006 (2009, eyebrow lift), with 510(k)s adding lift of lax submental and neck tissue (K121700, 2012) and decollete lines (K134032, 2014); PRIME cleared under K233996 (2024) with subsequent 2025-26 clearances expanding the platform — all confirmed via openFDA; match the K-number to the exact console model.

Regulatory data is compiled from public FDA 510(k) records and may lag recent clearances. Always confirm status with the manufacturer before purchase.

Treatment economics

What practices charge

$1,800-3,500 full face, $3,000-5,500 face+neck, $500-1,200 smaller zones; national averages near $2,700. Sold as a single annual treatment — each booking is a four-figure ticket.

Consumables & recurring cost

The whole economic story: DeepSEE transducers are line-limited (e.g., 2,400 lines) with expiration dates, ~$800-1,900 each depending on depth; a full face/neck uses multiple depths. Real provider cost ~$400-1,200 per treatment, sold only to registered accounts — counterfeit/"refilled" gray-market transducers are a documented industry problem Merz actively warns about. A 10-case/month practice can exceed $60k-100k/year in transducer spend.

Ideal for

Best-fit practice

Established medspas, derm, and plastics practices with consult-driven sales and clientele paying $2,500+ per session — 40-65, moderate laxity, surgery-averse, brand-aware. Wrong fit for discount-driven spas; the consumable load punishes low pricing.

Compliance

Medical director & delegation

Focused ultrasound typically delegated to RNs/NPs/PAs under physician oversight, with several states restricting further; because outcomes are so operator-dependent, Merz clinical training (which requires account standing) matters as much as the legal minimum.

Contraindications & screening

Open lesions or severe cystic acne in the area, implanted electrical devices, caution over metal implants/filler along planned lines, pregnancy, anticoagulation per protocol, and severe-laxity patients who need surgery.

Ownership

Warranty & service

PRIME consoles carry ~1-year Merz warranty; legacy consoles are increasingly end-of-life for parts as Merz pushes the PRIME upgrade cycle — get written confirmation of continued legacy support and transducer supply before buying used.

Resale & used market

Legacy consoles are plentiful and cheap precisely because of the transducer lockout — liquidity is high at $15k-45k but the buyer pool that can actually use them is small; values trend down as PRIME penetrates.